Trial Search Results

Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma

To evaluate the role of purging the hematopoietic cell graft on outcomes for non-Hodgkin's Lymphoma.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Institutes of Health (NIH)

Intervention(s):

  • Procedure: high dose chemo then auto hematopoietic cell transplant

Phase:

N/A

Eligibility


Inclusion Criteria:- relapsed NHL

Exclusion Criteria:- liver dysfunction

Ages Eligible for Study

N/A - 75 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
BMT Refferals
6507230822
Not Recruiting